600422.SHG KPC Pharmaceuticals Inc

Healthcare Pharmaceuticals Shanghai Stock Exchange
8.85 CNY
Close of Nov 5, 2026
7.45 14.05
Market cap
CNY 6.70B
P/E
-
P/B
1.39x
ROE
-10.0%
Dividend yield
3.39%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600422.SHG undervalued?

Graham number

The Graham number of KPC Pharmaceuticals Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

KPC Pharmaceuticals Inc fundamental analysis

No fundamental analysis for KPC Pharmaceuticals Inc yet.

KPC Pharmaceuticals Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About KPC Pharmaceuticals Inc

KPC Pharmaceuticals,Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs and natural drugs in the People's Republic of China and internationally. It offers artemisia annua series, panax notoginseng, gastrodia, artemether, comether tablets, specialty herbal products, classic prescription for bones and joint, antibiotics, immunosuppressive, oral products, injections, and other products, as w…

Full company profile